The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points

Cancer Research

Volumn 59, Issue 2, 1999, Pages 422-430

  Kobayashi, Hisataka ^a   Le, Nhat ^a   Kim, In Sook ^a   Kim, Meyoung Kon ^a   Pie, Jae Eun ^a   Drumm, Debra ^a   Paik, David S ^a   Waldmann, Thomas A ^b   Paik, Chang H ^a   Carrasquillo, Jorge A ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOLIC ACID; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; LYSINE;

ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG FORMULATION; GLOMERULUS FILTRATION; IMMUNOREACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISOELECTRIC POINT; KIDNEY PROXIMAL TUBULE; MOLECULAR WEIGHT; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SCINTIGRAPHY;

ANIMALS; FEMALE; FUROSEMIDE; GLYCOSYLATION; IMMUNOGLOBULIN FAB FRAGMENTS; IODINE RADIOISOTOPES; ISOELECTRIC POINT; KIDNEY; LYSINE; MICE; MICE, NUDE; RADIOIMMUNODETECTION; RECEPTORS, INTERLEUKIN-2; TISSUE DISTRIBUTION;

EID: 0033555629     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Reiter, Y., Wright, A. F. Tonge, D. W., and Pastan, I. Recombinant single-chain and disulfide-stabilized Fv-immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice. Int. J. Cancer, 67: 113-123, 1996.
2. Benhar, I., Reiter, Y., Pai, L. H., and Pastan, I. Administration of disulfide-stabilized Fv-immunotoxins B1(dsFv)-PE38 and B3(dsFv)-PE38 by continuous infusion increases their efficacy in curing large tumor xenografts in nude mice. Int. J. Cancer, 62: 351-355, 1995.
3. Behr, T. M., Sharkey, R. M., Sgouros, G., Blumenthal, R. D., Dunn, R. M., Kolbert, K., Griffiths, G. L., Siegel, J. A., Beeker, W. S., and Goldenberg, D. M. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry. Cancer (Phila.), 80: 2591-2610, 1997.
4. Goldenberg, D. M., Juweid, M., Dunn, R. M., and Sharkey, R. M. Cancer imaging with radiolabeled antibodies: new advances with technetium-99m-labeled monoclonal antibody Fab' fragments, especially CEA Scan and prospects for therapy. J. Nucl. Med. Technol., 25: 18-23, 1997.
5. Kamigaki, T., Yamamoto, M., Ohyanagi, H., Ohya, M., Shimazoe, T., Kono, A., Ohtani, W., Narita, Y., Ohkubo, M., and Saitoh, Y. Therapy and imaging of pancreatic carcinoma xenografts with radioiodine-labeled chimeric monoclonal antibody A10 and its Fab fragment. Jpn. J. Cancer Res., 86: 1216-1223, 1995.
6. 177Lu]α-[2-(4-aminophenyl) ethyl]-1,4,7,10-tetraaza-cyclodecane-1,4,7,10-tetraacetic acid-CC49 Fab radioimmunoconjugate. Cancer Res, 55: 5288-5295, 1995.
7. Halpern, S. E., Tarburton, J. P., Sudora, E., and Hagan, P. Alterations in an indium-111 Fab' under conditions of utilization. Eur. J. Nucl. Med., 19: 387-393, 1992.
8. Otsuji, E., Yamaguchi, T., Yamamoto, K., Matsumura, H., Tsuruta, H., Yata, Y., Nishi, H., Okamoto, K., Kitamura, K., and Takahashi, T. Decreased renal accumulation of biotinylated chimeric monoclonal antibody-neocarzinostatin conjugate after administration of avidin. Jpn. J. Cancer Res., 88: 205-212, 1997.
9. Carrasquillo, J. A. Radioimmunotherapy of leukemia and lymphoma. In: H. Wagner (ed.), Principles of Nuclear Medicine, Ed. 2, pp. 1117-1132. Philadelphia: W. B. Saunders and Co., 1996.
10. 125I radiolabeled T101 anti-CD5 monoclonal antibody. Int. J. Radiat. Appl. Instrument. B, 17: 201-207, 1990.
11. Wochner, R. D. Strober, W., and Waldmann, T. A. The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments. J. Exp. Med., 126: 207-221, 1967.
12. Sumpio, B. E., and Maack, T. Kinetics, competition, and selectivity of tubular absorption of proteins. Am. J. Physiol., 243: F379-F392, 1982.
13. Arend, W. P., and Silverblatt, F. J. Serum disappearance and catabolism of homologous immunoglobulin fragments in rats. Clin. Exp. Immunol., 22: 502-513, 1975.
14. 99mTc-labeled monoclonal antibody. Nucl. Med. Biol., 20: 617-623, 1993.
15. 99mTc-labeled anti-Tac dsFv. Cancer Res., 56: 3788-3795, 1996.
16. Hammond, P. J., Wade, A. F., Gwilliam, M. E., Peters, A. M., Myers, M. J., Gilbey, S. G., Bloom, S. R., and Calam, J. Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue. Br. J. Cancer, 67: 1437-1439, 1993.
17. 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy. Eur. J. Nucl. Med., 22: 608-616, 1995.
18. Rustom, R., Maltby, P., Grime, J. S., Stockdale, H. R., Critchley, M., and Bone, J. M. Effects of lysine infusion on the renal metabolism of aprotinin (Trasylol) in man. Clin. Sci. (Lond.), 83: 295-299, 1992.
19. Mogensen, C. E., and Solling, K. Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids. Scand. J. Clin. Lab. Invest., 37: 477-486, 1977.
20. Mogensen, C. E., Vittinghus, E., and Solling, K. Abnormal albumin excretion after two provocative renal tests in diabetes: physical exercise and lysine injection. Kidney Int., 16: 385-393, 1979.
21. Maack, T., Park, C. H., and Camargo, M. J. F. Renal filtration, transport, and metabolism of proteins. In: D. W. Seldin and G. Giebisch (eds.), The Kidney: Physiology and Pathophysiology, Ed. 2, pp. 3005-3038. New York: Raven Press Ltd., 1992.
22. 111In from labelled monoclonal antibody fragments. Nucl. Med. Commun., 16: 710-711, 1995.
23. Behr, T. M., Sharkey, R. M., Juweid, M. E., Blumenthal, R. D., Dunn, R. M., Griffiths, G. L., Bair, H. J., Wolf, F. G., Becker, W. S., and Goldenberg, D. M. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res., 55: 3825-34, 1995.
24. Behr, T. M., Becker, W. S., Sharkey, R. M., Juweid, M. E., Dunn, R. M., Bair, E. J., Wolf, F. G., and Goldenberg, D. M. Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion. J. Nucl. Med., 37: 829-833, 1996.
25. Kim, I. S., Yoo, T. M., Kobayashi, H., Kim, M-K., Le, N., Han, E. S., C., W. Q., Pastan, I., Carrasquillo, J. A., and Paik, C. H. Acylation with glycolate lowers pI of dsFv and reduces renal uptake of its Tc-99m label. J. Label. Compd. Radiopharm., XL: 422-424, 1997.
26. Kobayashi, H., Kim, I-S., Drumm, D., Kim, M-K., Paik, D. S., Le, N., Waldmann, T. A., Carrasquillo, J. A., and Paik, C. H. Favorable effects of glycolate conjugation on the biodistribution of humanized anti-Tac Fab fragment. J. Nucl. Med., in press, 1999.
27. Khaw, B-A., Klibanov, A., O'Donnell, S. M., Saito, T., Nossiff, N., Slinkin, M. A., Newell, J. B., Strauss, H. W., and Torchilin, V. P. Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers. J. Nucl. Med., 32: 1742-1753, 1991.
28. Khawli, L. A., Glasky, M. S., Alauddin, M. M., and Epstein, A. L. Improved tumor localization and radioimaging with chemically modified monoclonal antibodies. Can. Biol. Radiopharm., 11: 203-215, 1996.
29. Queen, C., Schneider, W. P., Selick, H. E., Payne, P. W., Landolfi, N. F., Duncan, J. F., Avdalovic, N. M., Levitt, M., Junghans, R. P., and Waldmann, T. A. A humanized antibody that binds to the interleukin 2 receptor. Proc. Natl. Acad. Sci. USA, 86: 10029-10033, 1989.
30. 131I-labelled human growth hormone of high specific radioactivity. Biochem. J., 89: 114-123, 1963.
31. Kobayashi, H., Sakahara, H., Saga, T., Hosono, M., Shirato, M., Kanda, H., Ishibashi, K., Watanabe, T., Endo, K., Ishiwata, I., and Konishi, J. A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer. Cancer Immunol. Immunother., 37: 143-149, 1993.
32. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., and Bunn, P. A., Jr. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods, 72: 77-89, 1984.
33. 212Bi-anti-Tac. Cancer Res, 54: 4362-4370, 1994.
34. Kreitman, R. J., and Pastan, I. Recombinant single-chain immunotoxins against T and B cell leukemias. Leuk. Lymphoma, 13: 1-10, 1994.
35. Chang, R. S., Ueki, I. F., Troy, J. L., Deen, W. M., Robertson, C. R., and Brenner, B. M. Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rat using neutral dextran. Biophys. J., 15: 887-906, 1975.
36. Rennke, H. G., Patel, Y., and Venkatachalam, M. A. Glomerular filtration of proteins: clearance of anionic, neutral, and calionic horseradish peroxidase in the rat. Kidney Int., 13: 278-288, 1978.
37. Bertolatus, J. A., and Hunsicker, L. G. Glomerular sieving of anionic and neutral bovine albumins in proteinuric rats. Kidney Int., 28: 467-476, 1985.
38. Guasch, A., Deen, W. M., and Myers, B. D. Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans. J. Clin. Invest., 92: 2274-2282, 1993.